Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

80.48USD
21 Apr 2017
Change (% chg)

$-0.54 (-0.67%)
Prev Close
$81.02
Open
$80.91
Day's High
$81.07
Day's Low
$80.29
Volume
1,418,301
Avg. Vol
1,542,329
52-wk High
$89.27
52-wk Low
$69.35

MDT.N

Chart for MDT.N

About

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group,... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $110,167.90
Shares Outstanding(Mil.): 1,368.89
Dividend: 0.43
Yield (%): 2.14

Financials

  MDT.N Industry Sector
P/E (TTM): 28.40 33.88 29.95
EPS (TTM): 2.83 -- --
ROI: 4.42 12.79 13.21
ROE: 7.92 14.87 14.38

LPC: US healthcare lending rouses from policy-induced sedation

NEW YORK US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

LPC: U.S. healthcare lending rouses from policy-induced sedation

NEW YORK U.S. drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

LPC: US healthcare lending rouses from policy-induced sedation

NEW YORK, April 20 US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

Goldman Sachs, J&J pull Wall Street lower

NEW YORK The S&P 500 fell for the fourth time in five sessions on Tuesday, weighed down by a drop in Goldman Sachs and Johnson & Johnson following their quarterly results, while geopolitical tensions added to investor caution. | Video

Apr 18 2017

BRIEF-FDA designates Medtronic worldwide voluntary field action on hvad(tm) system controllers

* FDA designates Medtronic worldwide voluntary field action on hvad(tm) system controllers and dc adapters as class i recall

Apr 18 2017

US STOCKS-Goldman Sachs, J&J pull Wall Street lower

NEW YORK, April 18 The S&P 500 fell for the fourth time in five sessions on Tuesday, weighed down by a drop in Goldman Sachs and Johnson & Johnson following their quarterly results, while geopolitical tensions added to investor caution.

Apr 18 2017

Deals of the day-Mergers and acquisitions

April 18 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Apr 18 2017

REFILE-US STOCKS-Wall Street falls as Goldman, J&J weigh

NEW YORK, April 18 U.S. stocks declined on Tuesday, weighed down by a drop in Goldman Sachs and Johnson & Johnson in the wake of their quarterly results, while geopolitical tensions continued to fuel investor caution.

Apr 18 2017

Fitch Revises Cardinal Health's Outlook to Negative Following $6B Deal

(The following statement was released by the rating agency) NEW YORK/BUENOS AIRES, April 18 (Fitch) Fitch Ratings has revised Cardinal Health, Inc.'s (Cardinal, NYSE: CAH) Rating Outlook to Negative from Stable following the announcement that it had agreed to acquire certain assets from Medtronic (Not Rated) for approximately $6 billion. KEY RATING DRIVERS The Negative Outlook reflects Fitch's expectation that Cardinal's leverage will remain elevated for the rating category for an extended perio

Apr 18 2017

BRIEF-Medtronic to divest part of its unit to Cardinal Health for $6.1 bln

* Medtronic signs definitive agreement to divest a portion of its patient monitoring & recovery division to Cardinal Health for $6.1 billion

Apr 18 2017

More From Around the Web

Earnings vs. Estimates